What Humana's Star Ratings Cut Means for Medicare Ad Budgets

Humana’s Star Ratings problem is now an ad-budget problem. The company is heading into 2026 with only about 20% of its Medicare Advantage members in plans rated 4 stars or higher, down from roughly 25% in 2025 and far below the 94% level reported for 2024.[1][2][3] That loss of quality-bonus eligibility has been reported as a roughly $3.5 billion revenue hole, and Humana cut its 2026 GAAP EPS guidance from $8.36 to $6.52 in July 2026, a 22% reduction.[2] For Medicare Advantage campaign teams, that is the part that matters: when bonus revenue falls away at that scale, acquisition budgets stop being treated as part of the normal operating rhythm and start being re-justified county by county, plan by plan, and channel by channel.

That is why the question is not simply why Humana is cutting Medicare Advantage spending after its Star Ratings decline. The better question is where the cuts show up first, and which channels still clear the finance test once the rating-driven revenue cushion is gone.

How Star Ratings Turn Into Campaign Restraint

The Star Ratings mechanism does not need a long primer here. Medicare Advantage plans with high enough ratings can qualify for Quality Bonus Payments, and those dollars can support richer benefits, pricing, operations, retention work, and the acquisition machinery around Annual Enrollment Period. When a large share of membership falls below the 4-star threshold, the budget question moves from marketing preference to plan economics.

Humana’s timeline is unusually sharp. Becker’s reported that 94% of Humana Medicare Advantage members were in 4-star-or-higher plans for 2024.[3] Fierce Healthcare later reported that about 25% of members were in 4-star-or-higher plans for 2025 and about 20% for 2026.[1] That means the company did not just lose a badge it could put in broker decks. It lost broad bonus eligibility across most of its Medicare Advantage membership.

The reported dollar effect is what moves this from a healthcare-finance story to a media-plan story. Quartz, via Yahoo Finance, reported that Humana cut 2026 GAAP EPS guidance from $8.36 to $6.52 in July 2026 and cited a roughly $3.5 billion revenue loss tied to lower Medicare Star Ratings.[2] The $3.5 billion figure is widely repeated in secondary reporting, but it should be treated with the right level of caution because the underlying source trail was not available in the crawled materials. Even with that caveat, the EPS cut is concrete enough to explain why campaign owners should expect pressure rather than business-as-usual AEP spending.

A plan can still spend into acquisition after a ratings hit. It just has less room to tolerate waste. Mail pieces sent into marginal counties, broad awareness placements without clean response accounting, and high-cost lead flows that create service or churn problems become harder to defend. The media buyer who used to argue from reach now has to argue from contribution.

The First Visible Cut Is Mail

The clearest reported campaign-side symptom is direct mail. Modern Healthcare, citing Competiscan data, reported a 15% year-over-year decline in Medicare Advantage direct mail marketing.[4] That figure matters because mail is often where Medicare Advantage pullbacks become visible before executives describe the same pressure in broader language. A carrier can reduce drops, suppress lower-propensity segments, shrink county coverage, delay creative refreshes, or tighten broker co-op activity without announcing a formal marketing reset.

The mail figure also needs a boundary. The underlying Competiscan methodology was not independently available in the research materials, and the reporting came through a paywalled Modern Healthcare article. So it should not be stretched into a complete measurement of Medicare Advantage ad spending. It is better read as an early, observable signal that broad acquisition activity is cooling.

That distinction matters for 2026 AEP planning. A 15% mail decline does not prove that every insurer is cutting every channel by the same amount. It does suggest that the old assumption—large senior files, big seasonal drops, repeated touches, and acceptable leakage—is being challenged by finance teams that now have less patience for acquisition volume that does not turn into durable, profitable enrollment.

Humana Is Not Operating in a Normal MA Market

Humana’s ratings collapse is company-specific, but the budget environment around it is not. Oliver Wyman reported that the Medicare Advantage industry had a $5.7 billion underwriting loss in 2024 and that nearly three-quarters of Medicare Advantage-focused companies reported losses.[5] In the same 2026 market overhaul analysis, Oliver Wyman reported that national plan count fell 10%, from 3,719 to 3,373, and that Humana, Aetna, UnitedHealthcare, and Elevance were each exiting at least 100 counties for 2026.[5]

County exits are not an abstract strategic move for media teams. They reduce the addressable map. They change which ZIP codes can be mailed, which local search campaigns still have a product behind them, which broker markets deserve co-op support, and which creative versions should never make it out of trafficking. A county that looked viable last year may still produce leads this year; the problem is that the plan may no longer want those leads, or may no longer be present to convert them.

The leadership mood is similarly cautious. HealthScape’s February 2026 survey found that 69% of Medicare Advantage leaders expected flat or declining plan-year 2027 enrollment, 70% expected benefit reductions, and no respondents planned richer benefits.[6] That is attitude data, not a direct media-spend forecast. Still, it lines up with what buyers hear when briefs come back narrower: fewer speculative markets, less appetite for general awareness, more pressure to prove which dollars produce enrollments worth keeping.

The federal bonus pool adds another layer. KFF reported in July 2026 that Quality Bonus Program spending would reach $13.4 billion in 2026, while bonus-qualifying enrollment fell to 68%, the lowest level since 2018 and down from 75% in 2025.[7] So the bonus program is still large, but access to it is tightening. Humana’s problem is severe, but it sits inside a broader market where more plans are being forced to choose between benefit richness, footprint, retention, and acquisition.

What Changes in the Channel Plan

The safest read for 2026 AEP is not “digital wins” or “mail is dead.” Both are too lazy. The stronger read is that spend moves toward channels and audiences where the buyer can defend the next dollar with cleaner economics: lower acquisition cost, better intent signals, clearer attribution, stronger retention value, or a direct tie to member actions that protect margin.

Direct mail is the channel with the clearest reported decline. For buyers, that means fewer broad drops, more suppression logic, and more pressure on modeled audiences. Mail will still have a role, especially where it reaches high-value prospects or supports broker and call-center conversion. But marginal circulation is the obvious place to cut when finance asks which spend can be removed without immediately damaging core retention or high-intent acquisition.

Display and CTV require more careful wording. The research materials do not contain reported CPM declines for Medicare Advantage display or CTV inventory. A softer CPM environment is a planning projection, not a sourced market fact. If broad acquisition budgets tighten and county footprints shrink, demand for less accountable upper- and mid-funnel impressions should weaken in some markets. That does not mean every publisher, platform, or local DMA sees lower pricing. It means buyers should be ready for more negotiable inventory where the campaign cannot prove response or enrollment value.

Search and other direct-response digital channels may move the other way. Again, this is an implication, not a reported SEM benchmark from the source set. When budgets compress, dollars often concentrate where intent is visible and where finance can see cost per call, cost per application, cost per enrollment, and downstream retention. That can make Medicare Advantage SEM more competitive even while total acquisition budgets are under pressure. Fewer dollars overall does not always mean cheaper clicks in the auctions that remain closest to conversion.

Retention work deserves more budget attention than it usually gets in campaign conversations. Ratings pressure, benefit reductions, county exits, and narrower acquisition economics all make existing members more valuable. A plan that spends heavily to replace avoidable churn is not being aggressive; it is paying twice. Expect more scrutiny on member communications, onboarding, plan-change education, pharmacy and provider disruption messaging, and service-triggered outreach where better handling can protect enrollment without buying a new lead.

The Practical Allocation Read

• Broad direct mail faces the most visible pressure because it is expensive, easy to reduce, and already showing a reported year-over-year decline.
• Display and CTV should be planned with more pricing discipline, especially where placements cannot show response quality or enrollment contribution.
• SEM and direct-response digital may absorb a larger share of remaining spend because they give buyers faster evidence of intent and cost efficiency.
• County-level eligibility and plan exits should be checked before audience building, not after media is bought.
• Retention economics should sit beside acquisition CAC in the budget conversation, not after it.

Where Buyers Should Be Careful

There are several places where the market can overstate what is known. The direct mail decline is sourced through reporting that cites Competiscan; it is not a full-channel spend audit available for independent inspection in the research set.[4] The $3.5 billion revenue impact is widely cited in secondary coverage, but the crawled materials did not include a primary Humana filing confirming that exact figure.[2] The channel implications for display, CTV, SEM, and direct-response digital are planning judgments drawn from financial compression and accountability pressure, not reported platform data.

It is also wrong to treat Humana’s ratings collapse as if it predicts every insurer’s AEP budget. Some plans will have different rating positions, county strategies, benefit designs, broker relationships, and capital tolerance. A carrier with stronger ratings in a priority market may still spend aggressively. A regional plan with limited losses may protect mail. A national plan exiting counties may cut media sharply in one geography and increase it in another.

The useful planning posture is narrower: Humana’s Star Ratings collapse shows what happens when quality-bonus economics stop supporting the same acquisition machine. The financial shock is large enough to make campaign waste politically and economically harder to defend. In that environment, media plans need tighter geography, cleaner response measurement, stronger retention logic, and less faith that last year’s volume plan still clears this year’s hurdle.

When bonus revenue disappears at this scale, the safest Medicare Advantage media plan is the one that can show where the next dollar goes, what it is expected to produce, and why that member or market is still worth buying.

References

1. Humana says 20% of members in 2026 Medicare Advantage plans with 4-plus stars, Fierce Healthcare
2. Humana cuts 2026 profit outlook on lower Medicare star ratings, Quartz/Yahoo Finance
3. Becker's Payer Issues report on Humana Medicare Advantage members in 4-star plans, Becker's Payer Issues
4. Cautious insurers downscale Medicare Advantage marketing, Modern Healthcare
5. Medicare Advantage Plans Continue Market Overhauls in 2026, Oliver Wyman
6. February 2026 Medicare Advantage leader survey, HealthScape, February 2026
7. Quality Bonus Program spending and bonus-qualifying enrollment in Medicare Advantage, KFF, July 2026